World Scientific
Skip main navigation
Close Drawer MenuOpen Drawer Menu

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Our website is made possible by displaying certain online content using javascript.
In order to view the full content, please disable your ad blocker or whitelist our website www.worldscientific.com.

System Upgrade on Fri, Jun 26th, 2020 at 5pm (ET)

During this period, our website will be offline for less than an hour but the E-commerce and registration of new users may not be available for up to 4 hours.
For online purchase, please visit us again. Contact us at [email protected] for any enquiries.
ArticleNo Access

Enhancement of PDT-cytotoxicity via ROS induced by indomethacin in metastatic breast cancer

    https://doi.org/10.1142/S1088424619501542Cited by:2
    Previous
    Next

    Abstract

    Breast cancer is one of the most common types of cancers prevalent in women. Several types of breast cancers can easily metastasize to bone and cause disease complications such as hypercalcemia and pathologic fracture, thus compromising the quality of life of people affected by it. Bisphosphonate drugs are often used for the treatment of bone metastasis to suppress osteoclastic bone resorption. However, bisphosphonate has adverse effects on the gastrointestinal tract and kidneys and also induces osteonecrosis of the jaw. Photodynamic therapy (PDT) is an alternative cancer treatment approach with minimal invasiveness. It is a combination treatment that uses photosensitizers, which accumulate in tumor cells, followed by laser irradiation. We previously reported that the cellular incorporation of 5-aminolevulinic acid (5-ALA), which was a precursor of protoporphyrin IX (PpIX), was regulated by reactive oxygen species derived from mitochondria (mitROS). In this study, we investigated the incorporation of 5-ALA, accumulation of PpIX, and subsequent effects on cell viability after laser irradiation of two different breast cancer cell lines with different metastaticites. The highly metastatic breast cancer cell line 4T1E/M3 showed a significant increase in ROS production after treatment with indomethacin (IND). In addition, IND treatment enhanced the cellular uptake of 5-ALA via PEPT1 upregulation in 4T1E/M3, but not in the non-metastatic cell line. Overall, metastatic breast cancer is likely to be sensitive to ROS and activate signaling pathways associated with 5-ALA transportation, suggesting that ALA-PDT could be an effective treatment with low invasiveness for metastatic breast cancer.

    This paper is part of the 2019 Women in Porphyrin Science special issue.

    References

    • 1. Latest Global Cancer Data: Cancer Burden Rises to 18.1 Million New Cases and 9.6 Million Cancer Deaths in 2018, International Agency for Research on Cancer, World Health Organization. Google Scholar
    • 2. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E and Zlotnik A . Nature 2001; 410: 50–56. Crossref, ISI, Google Scholar
    • 3. Coleman RE and Rubens RD . Br. J. Cancer 1987; 55: 61–66. Crossref, ISI, Google Scholar
    • 4. Coleman RE . Clin. Cancer Res. 2006; 12: 6243s–6249s. Crossref, ISI, Google Scholar
    • 5. Papapetrou PD . Hormones 2009; 8: 96–110. Crossref, Google Scholar
    • 6. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC and Golab J . CA Cancer J. Clin. 2011; 61: 250–281. Crossref, ISI, Google Scholar
    • 7. Moret F and Reddi E . J. Porphyrins Phthalocyanines 2017; 21: 239–256. Link, ISI, Google Scholar
    • 8. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F and Reulen HJ . Lancet Oncol. 2006; 7: 392–401. Crossref, ISI, Google Scholar
    • 9. Hadjipanayis CG, Widhalm G and Stummer W . Neurosurgery 2015; 77: 663–673. Crossref, ISI, Google Scholar
    • 10. Kriegmair M, Baumgartner R, Lumper W, Waidelich R and Hofstetter A . Br. J. Urol. 1996; 77: 667–671. Crossref, Google Scholar
    • 11. Ito H, Tamura M, Matsui H, Majima HJ, Indo HP and Hyodo I . J. Clin. Biochem. Nutr. 2014; 54: 81–85. Crossref, ISI, Google Scholar
    • 12. Kurokawa H, Ito H and Matsui H . Cells 2019; 8: 918. Crossref, Google Scholar
    • 13. Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, Noda H, Nabemoto S, Kurita S, Ota T, Ando H, Miyamoto K and Kaneko S . J. Biol. Chem. 2009; 284: 14809–14818. Crossref, ISI, Google Scholar
    • 14. Reuter S, Gupta SC, Chaturvedi MM and Aggarwal BB . Free Radic. Biol. Res. 2010; 49: 1603–1616. Crossref, ISI, Google Scholar
    • 15. Sullivan LB and Chandel NS . Cancer Metab. 2014; 2: 17. Crossref, Google Scholar
    • 16. Tamura M, Matsui H, Tomita T, Sadakata H, Indo HP, Majima HJ, Kaneko T and Hyodo I . J. Clin. Biochem. Nutr. 2014; 54: 12–17. Crossref, ISI, Google Scholar
    • 17. Hiyama K, Matsui H, Tamura M, Shimokawa O, Hiyama M, Kaneko T, Nagano Y, Hyodo I, Tanaka J, Miwa Y, Ogawa T, Nakanishi T and Tamai I . J. Porphyrins Phthalocyanines 2013; 17: 36–43. Link, ISI, Google Scholar
    • 18. Nagano Y, Matsui H, Shimokawa O, Hirayama A, Tamura M, Nakamura Y, Kaneko T, Rai K, Indo HP, Majima HJ and Hyodo I . J. Physiol. Pharmacol. 2012; 63: 137–142. ISI, Google Scholar
    • 19. Ito H, Matsui H, Hirayama A, Indo HP, Majima HJ and Hyodo I . J. Clin. Biochem. Nutr. 2016; 58: 180–185. Crossref, ISI, Google Scholar
    • 20. Liou GY and Storz P . Free Radic. Res. 2010; 44: 479–496. Crossref, ISI, Google Scholar
    • 21. Birben E, Sahiner UM, Sackesen C, Erzurum S and Kalayci O . World Allergy Organ J. 2012; 5: 9–19. Crossref, Google Scholar
    • 22. Hagiya Y, Endo Y, Yonemura Y, Takahashi K, Ishizuka M, Abe F, Tanaka T, Okura I, Nakajima M, Ishikawa T and Ogura S . Photodiagn. Photodyn. Ther. 2012; 9: 201–214. Crossref, Google Scholar
    • 23. Kurokawa H, Ito H, Terasaki M and Matsui H . Sci. Rep. 2019; 9: 1638. Crossref, Google Scholar
    • 24. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK and Ross DD . Proc. Natl. Acad. Sci. USA 1998; 95: 15665–15670. Crossref, ISI, Google Scholar
    • 25. Doyle L and Ross DD . Oncogene 2003; 22: 7340–7358. Crossref, ISI, Google Scholar
    • 26. Yamamoto F, Ohgari Y, Yamaki N, Kitajima S, Shimokawa O, Matsui H and Taketani S . Biochem. Biophys. Res. Commun. 2007; 353: 541–546. Crossref, ISI, Google Scholar
    • 27. Zhen J, Lu H, Wang XQ, Vaziri ND and Zhou XJ . Am. J. Hypertens. 2008; 21: 28–34. Crossref, ISI, Google Scholar
    • 28. Motoori S, Majima HJ, Ebara M, Kato H, Hirai F, Kakinuma S, Yamaguchi C, Ozawa T, Nagano T, Tsujii H and Saisho H . Cancer Res. 2001; 61: 5382–5388. ISI, Google Scholar
    • 29. Furukawa T, Kohno H, Tokunaga R and Taketani S . Biochem. J. 1995; 310: 533–538. Crossref, ISI, Google Scholar
    • 30. Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N and Okada T . Clin. Exp. Metastasis 2008; 25: 517–529. Crossref, ISI, Google Scholar
    • 31. Takahashi M, Miyazaki H, Furihata M, Sakai H, Konakahara T, Watanabe M and Okada T . Clin. Exp. Metastasis 2009; 26: 817–828. Crossref, ISI, Google Scholar
    Most comprehensive & up-to-date research on PORPHYRINS
    Handbook of Porphyrin Science now available in 44 volumes (9 sets)